ABUS vs EL · P/E 5.4, rev $6.2M vs rev $15.05B
Arbutus Biopharma Corp (ABUS) versus Estee Lauder Companies Inc (EL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. EL currently screens at market cap $31.92B.
Not investment advice. Open the ABUS and EL stock pages for the full models.
Not investment advice.